Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/16509
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorREZENDE, Leandro Fornias Machado de-
dc.contributor.authorSA, Thiago Herick de-
dc.contributor.authorMIELKE, Gregore Iven-
dc.contributor.authorVISCONDI, Juliana Yukari Kodaira-
dc.contributor.authorREY-LOPEZ, Juan Pablo-
dc.contributor.authorGARCIA, Leandro Martin Totaro-
dc.date.accessioned2016-10-17T16:52:18Z-
dc.date.available2016-10-17T16:52:18Z-
dc.date.issued2016-
dc.identifier.citationAMERICAN JOURNAL OF PREVENTIVE MEDICINE, v.51, n.2, p.253-263, 2016-
dc.identifier.issn0749-3797-
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/16509-
dc.description.abstractIntroduction: Recent studies have shown that sitting time is associated with increased risk of all-cause mortality, independent of moderate to vigorous physical activity. Less is known about the population-attributable fraction for all-cause mortality associated with sitting time, and the gains in life expectancy related to the elimination of this risk factor. Methods: In November 2015, data were gathered from one published meta-analysis, 54 adult surveys on sitting time distribution (from 2002 to 2011), in conjunction with national statistics on population size, life table, and overall deaths. Population-attributable fraction for all-cause mortality associated with sitting time > 3 hours/day was estimated for each country, WHO regions, and worldwide. Gains in life expectancy related to the elimination of sitting time > 3 hours/day was estimated using life table analysis. Results: Sitting time was responsible for 3.8% of all-cause mortality (about 433,000 deaths/year) among those 54 countries. All-cause mortality due to sitting time was higher in the countries from the Western Pacific region, followed by European, Eastern Mediterranean, American, and Southeast Asian countries. Eliminating sitting time would increase life expectancy by 0.20 years in those countries. Conclusions: Assuming that the effect of sitting time on all-cause mortality risk is independent of physical activity, reducing sitting time plays an important role in active lifestyle promotion, which is an important aspect of premature mortality prevention worldwide.-
dc.description.sponsorshipSao Paulo Research Foundation (FAPESP) [2014/25614-4, 2012/08565-4]-
dc.description.sponsorshipFederal Agency for Support and Evaluation of Graduate Education (CAPES)-
dc.description.sponsorshipBrazilian Federal Agency for Support and Evaluation of Graduate Educacional-
dc.language.isoeng-
dc.publisherELSEVIER SCIENCE INC-
dc.relation.ispartofAmerican Journal of Preventive Medicine-
dc.rightsrestrictedAccess-
dc.subject.otherphysical-activity-
dc.subject.othersedentary behavior-
dc.subject.otherlife expectancy-
dc.subject.otheradults-
dc.subject.otherhealth-
dc.subject.otherrisk-
dc.subject.otherdisease-
dc.subject.otherassociations-
dc.subject.otherburden-
dc.titleAll-Cause Mortality Attributable to Sitting Time Analysis of 54 Countries Worldwide-
dc.typearticle-
dc.rights.holderCopyright ELSEVIER SCIENCE INC-
dc.identifier.doi10.1016/j.amepre.2016.01.022-
dc.identifier.pmid27017420-
dc.subject.wosPublic, Environmental & Occupational Health-
dc.subject.wosMedicine, General & Internal-
dc.type.categoryoriginal article-
dc.type.versionpublishedVersion-
hcfmusp.author.externalSA, Thiago Herick de:Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, Sao Paulo, Brazil-
hcfmusp.author.externalMIELKE, Gregore Iven:Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, Brazil-
hcfmusp.author.externalREY-LOPEZ, Juan Pablo:Univ San Jorge, Fac Hlth Sci, Zaragoza, Spain-
hcfmusp.author.externalGARCIA, Leandro Martin Totaro:Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, Sao Paulo, Brazil-
hcfmusp.description.beginpage253-
hcfmusp.description.endpage263-
hcfmusp.description.issue2-
hcfmusp.description.volume51-
hcfmusp.origemWOS-
hcfmusp.origem.id2-s2.0-84962484744-
hcfmusp.origem.idWOS:000380256400016-
hcfmusp.publisher.cityNEW YORK-
hcfmusp.publisher.countryUSA-
hcfmusp.relation.referenceBauman A, 2011, AM J PREV MED, V41, P228, DOI 10.1016/j.amepre.2011.05.003-
hcfmusp.relation.referenceBennie JA, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-107-
hcfmusp.relation.referenceBrownson RC, 2005, ANNU REV PUBL HEALTH, V26, P421, DOI 10.1146/annurev.publhealth.26.021304.14437-
hcfmusp.relation.referenceBuckley JP, 2015, BRIT J SPORT MED, V49, P1357, DOI 10.1136/bjsports-2015-094618-
hcfmusp.relation.referenceChau JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080000-
hcfmusp.relation.referenceDunstan DW, 2012, DIABETES RES CLIN PR, V97, P368, DOI 10.1016/j.diabres.2012.05.020-
hcfmusp.relation.referenceFord ES, 2012, INT J EPIDEMIOL, V41, P1338, DOI 10.1093/ije/dys078-
hcfmusp.relation.referenceHagger-Johnson G, 2016, AM J PREV MED, V50, P154, DOI 10.1016/j.amepre.2015.06.025-
hcfmusp.relation.referenceHallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1-
hcfmusp.relation.referenceHamilton MT, 2008, CURR CARDIOVASC RISK, V2, P292, DOI 10.1007/S12170-008-0054-8-
hcfmusp.relation.referenceHealy GN, 2011, AM J PREV MED, V41, P216, DOI 10.1016/j.amepre.2011.05.005-
hcfmusp.relation.referenceHealy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046-
hcfmusp.relation.referenceHeath GW, 2012, LANCET, V380, P272, DOI 10.1016/S0140-6736(12)60816-2-
hcfmusp.relation.referenceKatzmarzyk PT, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000828-
hcfmusp.relation.referenceLee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9-
hcfmusp.relation.referenceLim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8-
hcfmusp.relation.referenceMatthews CE, 2015, MED SCI SPORT EXER, V47, P1833, DOI 10.1249/MSS.0000000000000621-
hcfmusp.relation.referenceMielke GI, 2014, PLOS ONE-
hcfmusp.relation.referenceOwen N, 2010, MAYO CLIN PROC, V85, P1138, DOI 10.4065/mcp.2010.0444-
hcfmusp.relation.referencePreston SH, 2011, AM J PUBLIC HEALTH, V101, P2137, DOI 10.2105/AJPH.2011.300219-
hcfmusp.relation.referencePrince SA, 2014, OBES REV, V15, P905, DOI 10.1111/obr.12215-
hcfmusp.relation.referencePulsford RM, 2015, INT J EPIDEMIOL, V44, P1909, DOI 10.1093/ije/dyv191-
hcfmusp.relation.referenceRenteria E, TOB CONTROL IN PRESS-
hcfmusp.relation.referenceRezende LFM, 2014, PLOS ONE, V9, DOI 10.1371/J0URNAL.P0NE.0105620-
hcfmusp.relation.referenceRockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15-
hcfmusp.relation.referenceRoss S. M., 2010, 1 COURSE PROBABILITY-
hcfmusp.relation.referenceRydin Y, 2012, LANCET, V379, P2079, DOI 10.1016/S0140-6736(12)60435-8-
hcfmusp.relation.referenceSmith L, 2015, SPORTS MED, V45, P449, DOI 10.1007/s40279-015-0310-2-
hcfmusp.relation.referenceSparling PB, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h100-
hcfmusp.relation.referenceThosar SS, 2012, MED SCI MONITOR, V18, pRA173-
hcfmusp.relation.referencevan der Ploeg HP, 2012, ARCH INTERN MED, V172, P494, DOI 10.1001/archinternmed.2011.2174-
hcfmusp.relation.referenceWorld Health Organization, 2010, GLOB REC PHYS ACT HL-
hcfmusp.relation.referenceWHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1-
hcfmusp.relation.referenceWHO, LIF TABL WHO MEMB ST-
dc.description.indexMEDLINE-
dc.identifier.eissn1873-2607-
hcfmusp.citation.scopus106-
hcfmusp.scopus.lastupdate2022-08-29-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - LIM/38
LIM/38 - Laboratório de Epidemiologia e Imunobiologia


Files in This Item:
File Description SizeFormat 
art_REZENDE_AllCause_Mortality_Attributable_to_Sitting_Time_Analysis_of_2016.PDF
  Restricted Access
publishedVersion (English)948.25 kBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.